NCT06017765

Brief Summary

The goal of this clinical trial is to pilot the effectiveness of an 8-week standardized Mindfulness Training program to decrease the psychiatric and somatic symptoms of prolonged grief disorder (PGD) and to examine changes in physiological and neuroimaging biomarkers of bereavement-related stress reactivity that are associated with Mindfulness Training in grieving adult patients (men and women, aged 18-60) who are diagnosed with PGD. The main questions it aims to answer are:

  • randomly assigned to immediately receiving an 8-week Mindfulness Training program or after a 12-week waitlist.
  • assessed for psychiatric and somatic symptoms and for physiological responses during a baseline, midpoint and endpoint visit, and at a one-month follow-up visit.
  • assessed for functional neuroimaging biomarkers of bereavement-related and general stress reactivity at the baseline and endpoint visits using a script-driven imagery task (which induces bereavement-related stress reactivity during an imagery of a personal situation related to the death compared to imagery of a neutral personal situation), and loud tones stress task (which induces general stress reactivity). Researchers will compare the Mindfulness Training group (which consists of patients with PGD who will receive the Mindfulness Training immediately) with the waitlist control group (which consists of patients with PGD who are waiting on a waitlist to receive the training after the Mindfulness Training group) to investigate if they differ in PGD symptom severity as well as physiological and neuroimaging biomarkers of stress reactivity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Aug 2023Jul 2026

First Submitted

Initial submission to the registry

July 20, 2023

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

2.7 years

First QC Date

July 20, 2023

Last Update Submit

July 21, 2025

Conditions

Keywords

Prolonged Grief DisorderBereavementMindfulness TrainingScript-driven ImageryStress ReactivityNeuroimaging

Outcome Measures

Primary Outcomes (1)

  • Mean change in Prolonged Grief Disorder (PGD) symptom severity from the pre-intervention baseline to the post-intervention endpoint visit.

    PGD symptom severity is assessed by the Inventory of Complicated Grief (ICG) questionnaire.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

Secondary Outcomes (15)

  • Mean change in Prolonged Grief Disorder (PGD) symptom severity from the pre-intervention baseline to the post-intervention endpoint, and one-month follow-up visit.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

  • Mean change in Posttraumatic Stress Disorder (PTSD) symptom severity in relation to the death, from the pre-intervention baseline to the post-intervention endpoint, and one-month follow-up visit.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

  • Mean change in Depression symptom severity from the pre-intervention baseline to the post-intervention endpoint, and one-month follow-up visit.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

  • Mean change in somatic complaints from the pre-intervention baseline to the post-intervention endpoint, and one-month follow-up visit.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

  • Mean change in the ability to cope with stress from the pre-intervention baseline to the post-intervention endpoint, and one-month follow-up visit.

    Assessed during the pre-intervention baseline (week 0), post-intervention endpoint (week 8), and one-month follow-up visit (week 12).

  • +10 more secondary outcomes

Other Outcomes (9)

  • Characteristics of the death.

    Assessed during the screening visit (week-4 until 0).

  • The absence of diagnostic exclusion criteria and co-occurring Axis-I psychiatric disorders.

    Assessed during the screening visit (week-4 until 0).

  • Socio-demographic variables.

    Assessed during the screening visit (week-4 until 0).

  • +6 more other outcomes

Study Arms (2)

Immediate Meditation Training group

EXPERIMENTAL

The Immediate Meditation Training group will immediately receive 8 weekly sessions of Mindfulness Training within 4 weeks after the Baseline visit (V0, during which participants are randomized).

Behavioral: Meditation Training

Waitlist Control group

OTHER

The Waitlist Control group will receive the Mindfulness Training after a waiting time of 12 weeks. Participants in this group will not receive any type of intervention before this and will wait till the Immediate Meditation Training group finished all assessment visits (including the follow-up visit in week 12 (V3)).

Behavioral: Waitlist

Interventions

The Meditation Training consists of 8 weekly sessions of Mindfulness Training and is adapted from the group-based Stress Management and Resiliency Training - Relaxation Response Resiliency Program, SMART-3RP. This training is structured around the following four goals: 1. Education about stress response 2. Elicitation of the Relaxation Response through Mindfulness Training 3. Creating adaptive perspectives 4. Coping strategiest.

Also known as: Mindfulness Training, SMART
Immediate Meditation Training group
WaitlistBEHAVIORAL

The waitlist consists of a waiting time of 12 weeks during which participants will nog receive any type of intervention.

Waitlist Control group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Must have lost a loved one (spouse, romantic partner, parent, child, sibling, close friend)
  • Must have a score \>29 on the Inventory of Complicated Grief (ICG)
  • Clinical diagnosis of Prolonged Grief Disorder as assessed by the Structured Clinical Interview for Complicated Grief (SCI-CG)

You may not qualify if:

  • History of a lifetime clinical diagnosis of schizophrenia
  • History of a lifetime clinical diagnosis of bipolar disorder
  • History of a lifetime clinical diagnosis of a psychotic disorder
  • Current diagnosis of substance or alcohol use disorder within the past 12 months
  • History of a neurologic disease, seizures, stroke or head injury resulting in prolonged loss of consciousness and/or neurological sequelae
  • Current pregnancy as assessed by a urinary pregnancy test at screening during the Screening (week -4 until 0), Baseline (week 0) or Endpoint visit (week 8), or lack of use approved methods birth control for women of childbearing age
  • Currently practice of mind-body techniques at least once a week (e.g., yoga) in the past 3 months
  • Currently undergoing concomitant psychotherapy for grief (any psychotherapy)
  • Left-handedness
  • Current use of medications that would affect cerebral metabolism
  • Any contraindications to Magnetic Resonance Imaging (MRI)
  • Being under legal guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Caen et Université de Caen Normandie - Centre Esquirol Adult Psychiatry

Caen, Calvados, 14000, France

RECRUITING

Related Publications (51)

  • Benson H, Greenwood MM, Klemchuk H. The relaxation response: psychophysiologic aspects and clinical applications. Int J Psychiatry Med. 1975;6(1-2):87-98. doi: 10.2190/376W-E4MT-QM6Q-H0UM.

    PMID: 773864BACKGROUND
  • Borysenko, J. (1988). Minding the Body Mending the Mind. New York, Bantam.

    BACKGROUND
  • Bowlby, J. (1980). Attachment and loss, volume 3: loss; sadness and depression.

    BACKGROUND
  • Bui E, Mauro C, Robinaugh DJ, Skritskaya NA, Wang Y, Gribbin C, Ghesquiere A, Horenstein A, Duan N, Reynolds C, Zisook S, Simon NM, Shear MK. THE STRUCTURED CLINICAL INTERVIEW FOR COMPLICATED GRIEF: RELIABILITY, VALIDITY, AND EXPLORATORY FACTOR ANALYSIS. Depress Anxiety. 2015 Jul;32(7):485-92. doi: 10.1002/da.22385. Epub 2015 Jun 9.

    PMID: 26061724BACKGROUND
  • Bui E, Blackburn AM, Brenner LH, Laifer LM, Park ER, Fricchione GL, Sylvia LG. Military and Veteran Caregivers' Perspectives of Stressors and a Mind-Body Program. Issues Ment Health Nurs. 2018 Oct;39(10):850-857. doi: 10.1080/01612840.2018.1485796. Epub 2018 Sep 13.

    PMID: 30212258BACKGROUND
  • Eric Bui, Ilana Ander & Clara Jaussaud. (2021). Grief in the time of COVID-19: An editorial, International Journal of Mental Health, 50:1, 1-3, DOI: 10.1080/00207411.2020.1870847

    BACKGROUND
  • Carson MA, Metzger LJ, Lasko NB, Paulus LA, Morse AE, Pitman RK, Orr SP. Physiologic reactivity to startling tones in female Vietnam nurse veterans with PTSD. J Trauma Stress. 2007 Oct;20(5):657-66. doi: 10.1002/jts.20218.

    PMID: 17955532BACKGROUND
  • Currier JM, Neimeyer RA, Berman JS. The effectiveness of psychotherapeutic interventions for bereaved persons: a comprehensive quantitative review. Psychol Bull. 2008 Sep;134(5):648-661. doi: 10.1037/0033-2909.134.5.648.

    PMID: 18729566BACKGROUND
  • Dawson, M.E., Schell, A.M., and Filion, D.L. (2017). The electrodermal system. In J.T. Cacioppo, L.G. Tassinary, G.G. Berntson (Eds.), Handbook of Psychophysiology, Cambridge University Press, New York, NY, pp. 217-243.

    BACKGROUND
  • Guy W. (1979). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, U.S. Department of Health, Education, and Welfare.

    BACKGROUND
  • Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH, Simon NM. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug;74(8):786-92. doi: 10.4088/JCP.12m08083.

    PMID: 23541163BACKGROUND
  • Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 Apr;262:328-332. doi: 10.1016/j.psychres.2017.01.006. Epub 2017 Jan 26.

    PMID: 28131433BACKGROUND
  • Hoge EA, Bui E, Mete M, Dutton MA, Baker AW, Simon NM. Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Jan 1;80(1):13-21. doi: 10.1001/jamapsychiatry.2022.3679.

    PMID: 36350591BACKGROUND
  • Kabat-Zinn, J. (1990). Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness, Bantam Dell.

    BACKGROUND
  • Kang, Y., Gruber, J., & Gray, J. R. (2013). Mindfulness and De-Automatization. Emotion Review, 5(2), 192-201. https://doi.org/10.1177/1754073912451629

    BACKGROUND
  • Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau MA, Paquin K, Hofmann SG. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev. 2013 Aug;33(6):763-71. doi: 10.1016/j.cpr.2013.05.005. Epub 2013 Jun 7.

    PMID: 23796855BACKGROUND
  • Lang PJ. Presidential address, 1978. A bio-informational theory of emotional imagery. Psychophysiology. 1979 Nov;16(6):495-512. doi: 10.1111/j.1469-8986.1979.tb01511.x. No abstract available.

    PMID: 515293BACKGROUND
  • Latham AE, Prigerson HG. Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav. 2004 Winter;34(4):350-62. doi: 10.1521/suli.34.4.350.53737.

    PMID: 15585457BACKGROUND
  • Laurie A, Neimeyer RA. African Americans in bereavement: grief as a function of ethnicity. Omega (Westport). 2008;57(2):173-93. doi: 10.2190/OM.57.2.d.

    PMID: 18680889BACKGROUND
  • LeBlanc NJ, Unger LD, McNally RJ. Emotional and physiological reactivity in Complicated Grief. J Affect Disord. 2016 Apr;194:98-104. doi: 10.1016/j.jad.2016.01.024. Epub 2016 Jan 13.

    PMID: 26803781BACKGROUND
  • Lichtenthal WG, Nilsson M, Kissane DW, Breitbart W, Kacel E, Jones EC, Prigerson HG. Underutilization of mental health services among bereaved caregivers with prolonged grief disorder. Psychiatr Serv. 2011 Oct;62(10):1225-9. doi: 10.1176/ps.62.10.pss6210_1225.

    PMID: 21969652BACKGROUND
  • Marchand WR. Neural mechanisms of mindfulness and meditation: Evidence from neuroimaging studies. World J Radiol. 2014 Jul 28;6(7):471-9. doi: 10.4329/wjr.v6.i7.471.

    PMID: 25071887BACKGROUND
  • Moon JR, Kondo N, Glymour MM, Subramanian SV. Widowhood and mortality: a meta-analysis. PLoS One. 2011;6(8):e23465. doi: 10.1371/journal.pone.0023465. Epub 2011 Aug 17.

    PMID: 21858130BACKGROUND
  • Newson RS, Boelen PA, Hek K, Hofman A, Tiemeier H. The prevalence and characteristics of complicated grief in older adults. J Affect Disord. 2011 Jul;132(1-2):231-8. doi: 10.1016/j.jad.2011.02.021. Epub 2011 Mar 12.

    PMID: 21397336BACKGROUND
  • O'Connor MF. Immunological and neuroimaging biomarkers of complicated grief. Dialogues Clin Neurosci. 2012 Jun;14(2):141-8. doi: 10.31887/DCNS.2012.14.2/mfoconnor.

    PMID: 22754286BACKGROUND
  • O'Connor MF, Wellisch DK, Stanton AL, Eisenberger NI, Irwin MR, Lieberman MD. Craving love? Enduring grief activates brain's reward center. Neuroimage. 2008 Aug 15;42(2):969-72. doi: 10.1016/j.neuroimage.2008.04.256. Epub 2008 May 10.

    PMID: 18559294BACKGROUND
  • Oltjenbruns KA. Ethnicity and the grief response: Mexican American versus Anglo American college students. Death Stud. 1998;22(2):141-55. doi: 10.1080/074811898201641.

    PMID: 10182423BACKGROUND
  • Orr SP, Pitman RK, Lasko NB, Herz LR. Psychophysiological assessment of posttraumatic stress disorder imagery in World War II and Korean combat veterans. J Abnorm Psychol. 1993 Feb;102(1):152-9. doi: 10.1037//0021-843x.102.1.152.

    PMID: 8436691BACKGROUND
  • Park ER, Traeger L, Vranceanu AM, Scult M, Lerner JA, Benson H, Denninger J, Fricchione GL. The development of a patient-centered program based on the relaxation response: the Relaxation Response Resiliency Program (3RP). Psychosomatics. 2013 Mar-Apr;54(2):165-74. doi: 10.1016/j.psym.2012.09.001. Epub 2013 Jan 22.

    PMID: 23352048BACKGROUND
  • Pole N, Neylan TC, Best SR, Orr SP, Marmar CR. Fear-potentiated startle and posttraumatic stress symptoms in urban police officers. J Trauma Stress. 2003 Oct;16(5):471-9. doi: 10.1023/A:1025758411370.

    PMID: 14584631BACKGROUND
  • Prigerson HG, Maciejewski PK, Reynolds CF 3rd, Bierhals AJ, Newsom JT, Fasiczka A, Frank E, Doman J, Miller M. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res. 1995 Nov 29;59(1-2):65-79. doi: 10.1016/0165-1781(95)02757-2.

    PMID: 8771222BACKGROUND
  • Prigerson HG, Bierhals AJ, Kasl SV, Reynolds CF 3rd, Shear MK, Day N, Beery LC, Newsom JT, Jacobs S. Traumatic grief as a risk factor for mental and physical morbidity. Am J Psychiatry. 1997 May;154(5):616-23. doi: 10.1176/ajp.154.5.616.

    PMID: 9137115BACKGROUND
  • Rauch SAM, Kim HM, Lederman S, Sullivan G, Acierno R, Tuerk PW, Simon NM, Venners MR, Norman SB, Allard CB, Porter KE, Martis B, Bui E, Baker AW; PROGrESS Team. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD. J Clin Psychiatry. 2021 Jun 15;82(4):20m13752. doi: 10.4088/JCP.20m13752.

    PMID: 34133087BACKGROUND
  • Reynolds CF 3rd, Miller MD, Pasternak RE, Frank E, Perel JM, Cornes C, Houck PR, Mazumdar S, Dew MA, Kupfer DJ. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry. 1999 Feb;156(2):202-8. doi: 10.1176/ajp.156.2.202.

    PMID: 9989555BACKGROUND
  • Rostila M, Saarela J, Kawachi I, Hjern A. Testing the anniversary reaction: causal effects of bereavement in a nationwide follow-up study from Sweden. Eur J Epidemiol. 2015 Mar;30(3):239-47. doi: 10.1007/s10654-015-9989-5. Epub 2015 Jan 17.

    PMID: 25595319BACKGROUND
  • Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8.

    PMID: 12946886BACKGROUND
  • Samuelson M, Foret M, Baim M, Lerner J, Fricchione G, Benson H, Dusek J, Yeung A. Exploring the effectiveness of a comprehensive mind-body intervention for medical symptom relief. J Altern Complement Med. 2010 Feb;16(2):187-92. doi: 10.1089/acm.2009.0142.

    PMID: 20180692BACKGROUND
  • Sbarra DA, Hazan C. Coregulation, dysregulation, self-regulation: an integrative analysis and empirical agenda for understanding adult attachment, separation, loss, and recovery. Pers Soc Psychol Rev. 2008 May;12(2):141-67. doi: 10.1177/1088868308315702.

    PMID: 18453476BACKGROUND
  • Selye, H. (1956). The stress of life. McGraw-Hill.

    BACKGROUND
  • Shear K, Frank E, Houck PR, Reynolds CF 3rd. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005 Jun 1;293(21):2601-8. doi: 10.1001/jama.293.21.2601.

    PMID: 15928281BACKGROUND
  • Shear MK, Ghesquiere A, Glickman K. Bereavement and complicated grief. Curr Psychiatry Rep. 2013 Nov;15(11):406. doi: 10.1007/s11920-013-0406-z.

    PMID: 24068457BACKGROUND
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.

    PMID: 9881538BACKGROUND
  • Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen Psychiatry. 2004 Feb;61(2):168-76. doi: 10.1001/archpsyc.61.2.168.

    PMID: 14757593BACKGROUND
  • Shor E, Roelfs DJ, Curreli M, Clemow L, Burg MM, Schwartz JE. Widowhood and mortality: a meta-analysis and meta-regression. Demography. 2012 May;49(2):575-606. doi: 10.1007/s13524-012-0096-x.

    PMID: 22427278BACKGROUND
  • Simon NM, Hofmann SG, Rosenfield D, Hoeppner SS, Hoge EA, Bui E, Khalsa SBS. Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021 Jan 1;78(1):13-20. doi: 10.1001/jamapsychiatry.2020.2496.

    PMID: 32805013BACKGROUND
  • Thompson LW, Breckenridge JN, Gallagher D, Peterson J. Effects of bereavement on self-perceptions of physical health in elderly widows and widowers. J Gerontol. 1984 May;39(3):309-14. doi: 10.1093/geronj/39.3.309.

    PMID: 6715808BACKGROUND
  • Vranceanu AM, Riklin E, Merker VL, Macklin EA, Park ER, Plotkin SR. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT. Neurology. 2016 Aug 23;87(8):806-14. doi: 10.1212/WNL.0000000000003005. Epub 2016 Jul 22.

    PMID: 27449066BACKGROUND
  • Waller A, Turon H, Mansfield E, Clark K, Hobden B, Sanson-Fisher R. Assisting the bereaved: A systematic review of the evidence for grief counselling. Palliat Med. 2016 Feb;30(2):132-48. doi: 10.1177/0269216315588728. Epub 2015 Sep 28.

    PMID: 26415735BACKGROUND
  • Wittouck C, Van Autreve S, De Jaegere E, Portzky G, van Heeringen K. The prevention and treatment of complicated grief: a meta-analysis. Clin Psychol Rev. 2011 Feb;31(1):69-78. doi: 10.1016/j.cpr.2010.09.005. Epub 2010 Sep 24.

    PMID: 21130937BACKGROUND
  • Zisook S, Shear K. Grief and bereavement: what psychiatrists need to know. World Psychiatry. 2009 Jun;8(2):67-74. doi: 10.1002/j.2051-5545.2009.tb00217.x.

    PMID: 19516922BACKGROUND
  • American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). American Psychiatric Publishing, Inc.. https://doi.org/10.1176/appi.books.9780890425596

    BACKGROUND

Related Links

MeSH Terms

Conditions

Prolonged Grief Disorder

Interventions

Waiting Lists

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Appointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Officials

  • Eric BUI, Professor

    CHU de Caen, Université de Caen Normandie, INSERM U1237, PhIND

    PRINCIPAL INVESTIGATOR
  • Annick Haelewyn-Razafimandimby, Associate Pr

    INSERM U1237, PhIND

    STUDY DIRECTOR
  • Charlotte Hilberdink, Postdoc

    INSERM U1237, PhIND

    STUDY CHAIR

Central Study Contacts

Annick Haelewyn-Razafimandimby, Associate Pr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participants will be assessed for psychiatric symptoms (primary objective) by blinded Independent Evaluators, who will not be involved in the mindfulness training sessions. Participants will be instructed to keep their evaluators blinded to the randomization. Blinded Independent Evaluators will be clinical psychologists who are fully trained in assessing the different measures.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study model is a pilot randomized waitlist controlled trial of an 8-session mindfulness training program (i.e., Stress Management and Resiliency Training, SMART program) delivered weekly for Prolonged Grief Disorder, either within 4 weeks (immediate) or after 12 weeks (waitlist). After participants have completed the baseline assessment (V0), they will be randomly assigned (1:1 randomization) to either the immediate mindfulness training group or the waitlist control group. The waitlist control group will wait for 12 weeks (when the immediate intervention group finished all study procedures, including the follow-up assessment) before receiving the mindfulness training, which is the same intervention as employed in the immediate intervention group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 30, 2023

Study Start

August 1, 2023

Primary Completion

April 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

July 24, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations